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Abstract
Detailed understanding of the signaling intermediates that confer the sensing of intracellular viral
nucleic acids for induction of type I interferons is critical for strategies to curtail viral mechanisms
that impede innate immune defenses. Here we show that the activation of the microtubule-
associated guanine nucleotide exchange factor GEF-H1, encoded by Arhgef2, is essential for
sensing of foreign RNA by RIG-I-like receptors. Activation of GEF-H1 controls RIG-I and Mda5-
dependent phosphorylation of IRF3 and induction of interferon-β expression in macrophages.
Generation of Arhgef2−/− mice revealed a pronounced signaling defect that prevented antiviral
host responses to encephalomyocarditis virus and influenza A virus. Microtubule networks
sequester GEF-H1 that upon activation is released to enable antiviral signaling by intracellular
nucleic acid detection pathways.
The induction of type I interferon (IFN) and activation of IFN-inducible genes are central to
innate immune defenses against viral infection1. Intracellular sensors for microbial nucleic
acids initiate complex signaling cascades that lead to the induction of proinflammatory
cytokines and type I IFN for antiviral innate immune responses and the development of
adaptive immunity2.
Corresponding author: Hans-Christian Reinecker, M.D., Massachusetts General Hospital 55 Fruit Street GRJ 711, Boston
Massachusetts, USA 02114, Tel: 617-724-2172; Fax: 617-726-3673 hans-christian_reinecker@hms.havard.edu..
Note: Supplementary Information is available in the online version of the paper.
AUTHOR CONTRIBUTIONS
HSC, YZ, JHS, SL, NW, and MB carried out experiments; KJ, AHS and CT supported the development of research tools and mice;
KJ provided virus and advised on virus infection experiments; HCR conceived of, directed all research and along with HSC, prepared
the manuscript.
COMPETING FINICIAL INTERESTS
The authors declare no competing financial interests.
NIH Public Access
Author Manuscript
Nat Immunol. Author manuscript; available in PMC 2014 July 01.
Published in final edited form as:
Nat Immunol. 2014 January ; 15(1): 63–71. doi:10.1038/ni.2766.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tViral targeting of dynein-based transport mechanisms play an important role for intracellular
movements and replication of viral pathogens3, although it is unresolved how microtubule-
based trafficking of signaling components contributes to the induction of antiviral defenses.
GEF-H1, also called lfc in mice, was originally identified as a member of the Dbl family
that is sequestered on microtubules and directs spatio-temporal activation of Rho GTPases4.
Inactive GEF-H1 binds to the dynein motor complex on microtubules5. GEF-H1 can be
activated and released from microtubules upon cellular interactions with bacterial
effectors6,7 and subsequently contributes to intracellular pathogen recognition7,8.
The innate immune system senses viral infection through cytosolic and transmembrane
receptors leading to activation of cell type-specific regulatory networks that activate IFN
regulatory factors (IRFs) and NF-κB for the induction of type I interferons and
proinflammatory cytokines. IFN-β expression is initially induced after viral RNA binding to
Toll-like receptors (TLRs) that signal through MyD88 and TRIF9. Single stranded viral
RNA (ssRNA) can be detected by TLR7 in endosomes10. Double-stranded viral RNA
(dsRNA) can be recognized by endosomal TLR311. In addition cell surface TLRs such as
TLR4 and TLR2 are activated by viral glycoproteins12.
During viral replication several members of the DExD/H-box helicases (DDX) protein
family comprised of RNA and DNA helicases function as viral RNA and DNA sensors13,14.
The CARD domain-containing DDX proteins, retinoic acid-inducible gene I (RIG-I) and
melanoma differentiation-associated gene 5 (Mda5), also recognized as RIG-I-like receptors
(RLR), are important inducers of innate immunity and recognize complementary variants of
viral RNA to distinguish between virus families15,16. Mda5 is required for type I IFN
responses to long cytoplasmic viral and synthetic dsRNA and is activated by
picornavirus1517, whereas RIG-I recognizes short blunt or 5′-triphosphorylated ends of viral
genomic RNA segments and is required for defense activation against influenza,
paramyxovirus and rhabdovirus families16,17,18,19. RIG-I and Mda5 signal transduction
requires mitochondrial antiviral signaling protein (MAVS), also called IFN-β promoter
stimulator 1 (IPS-1), for the activation of TBK1 (TANK [TRAF (tumour necrosis factor
receptor-associated factor) family member-associated nuclear factor κB activator]-binding
kinase 1) and IKKε that mediate the phosphorylation of IRF3 for the induction of type I
IFNs20. TBK1 and IRF3 activation also occurs downstream of stimulator of interferon genes
(STING; also known as TMEM173, MPYS, ERIS or MITA), in the detection of viral
nucleic acids and B-form DNA (B-DNA or poly(dA:dT)) by DDX proteins)21.
Here we demonstrate that GEF-H1 mediates the induction of antiviral host defenses by
cytosolic receptors RIG-I and Mda5 in macrophages. The recognition of viral RNA and
synthetic dsRNA in the MAVS pathway was dependent on microtubule networks that were
required for the activation and interaction of GEF-H1 with TBK1-IKKε for the induction of
IRF3 phosphorylation and subsequent induction of Ifnb1 gene expression. In contrast,
deletion of GEF-H1 or disruption of microtubule function in macrophages still allowed NF-
κB activation by cell surface and endosomal TLR activation. Consequently, GEF-H1 was
required for the restriction of ssRNA virus replication and the induction of antiviral host
defense against EMCV and influenza A.
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tRESULTS
GEF-H1 controls RLR signaling
To define the role of GEF-H1 in innate immune activation by foreign nucleic acids, we
generated GEF-H1-deficient mice using C57BL/6 embryonic stem cells with a gene-trap
insertion between exons 4 and 5 of Arhgef2 on mouse chromosome 3 that prevents GFH-H1
mRNA (Fig. 1a) and protein expression (Fig. 1b). These mice had normal T cell, B cell and
mononuclear phagocyte numbers in spleen and lymph nodes (Supplementary Fig. 1).
IFN-β protein secretion and mRNA expression were determined in response to 1-8 kb (high
molecular weight, HMW) polyriboinosinic:polyribocytidylic acid (poly(I:C)) as a ligand for
Mda5 or 0.3-1.2 kb (low molecular weight, LMW) poly(I:C) and 5′-triphosphate (5′ppp)-
double-stranded (ds)RNA were used as synthetic ligands for RIG-I18. In addition, cyclic
diguanosine monophosphate (c-di-GMP) was used as a DDX41 ligand that induces STING-
dependent IFN-β expression22. Expression of Ifnb1 mRNA was significantly reduced in
bone marrow-derived macrophages derived from GEF-H1-deficient mice in response to
MAVS and STING-mediated recognition of nucleic acids (Fig. 1c). In contrast, GEF-H1-
deficient macrophages upregulated Ifnb1 mRNA expression in response to TLR1/2, TLR2,
TLR4, TLR5, TLR2/6, TLR7 and TLR9 activation by specific ligands comparable to wild-
type macrophages (Fig. 1d).
The lack of transcriptional activation of Ifnb1 upon RIG-I activation by 5′ppp-dsRNA
resulted in significantly less IFN-β secretion in GEF-H1-deficient macrophages compared to
wild-type macrophages (Fig. 1e). GEF-H1-deficient macrophages also secreted significantly
less IFN-β after transfection of HMW and LMW poly(I:C) (Fig. 1f), and even demonstrated
significantly attenuated IFN-β secretion when HMW poly(I:C) was directly added to the
culture medium (Fig. 1g). Furthermore, GEF-H1 expression itself was upregulated by RIG-I
signaling initiated by 5′ppp-dsRNA transfection into macrophages (Fig. 1h). Remarkably,
two intact alleles of Arhgef2 were required to induce a full response to poly(I:C), since
macrophages heterozygous for gene-trap insertion also demonstrated impaired Ifnb1 mRNA
expression (Fig. 1i). GEF-H1-deficient macrophages also demonstrated reduced Il6 and Tnf
mRNA expression in response to 5′ppp-dsRNA, indicating a profound innate signaling
defect in the activation of MAVS-dependent RLR signaling (Fig. 1j). In contrast, TRIF- and
MyD88-mediated induction of IFN-β secretion and Il6 and Tnf mRNA expression were not
reduced in GEF-H1-deficient macrophages in response to the TLR4 ligand
lipopolysaccharide (LPS) (Supplementary Fig. 2).
The RLR signaling deficiency in GEF-H1-deficient macrophages was not due to impaired
poly(I:C) uptake. HMW rhodamine-labeled poly(I:C) was similarly absorbed from the
medium in GEF-H1-deficient and wild-type macrophages and found in association with
vesicular and tubular compartments in wild-type and GEF-H1-deficient macrophages
(Supplementary Fig. 3a,b). Together these data indicated that GEF-H1 expression is induced
by foreign intracellular dsRNA and required for the signaling of intracellular nucleotide
sensors leading to IFN-β secretion and proinflammatory cytokine expression in
macrophages.
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RLRs-induced type I IFN gene transcription requires MAVS and TBK1-IKKε and is
mediated primarily through IRF323. IRF3 is localized in the cytoplasm and, upon
stimulation, becomes activated by serine/threonine phosphorylation leading to nuclear
translocation and binding to recognition sequences in the promoters and enhancers of type I
IFNs20. To determine whether GEF-H1-dependent type I interferon induction was mediated
by IRF3 phosphorylation and nuclear translocation in response to RLR activation, we
stimulated GEF-H1-deficient and wild-type macrophages with the RIG-I ligand 5′ppp-
dsRNA and analyzed the resulting phosphorylation of IRF3 in cell lysates as well as nuclear
translocation of IRF3. Phosphorylation of IRF3 in response to RIG-I activation was
significantly reduced in GEF-H1-deficient macrophages when compared to wild-type
macrophages (Fig. 2a). IRF3 remained undetectable 4 h after 5′ppp-dsRNA stimulation in
the nuclei of GEF-H1-deficient macrophages, demonstrating a profound deficiency in IRF3
activation (Fig. 2b). In contrast, IRF3 phosphorylation in response to LPS occurred at much
lower amounts in bone marrow-derived macrophages under same conditions but was
detectable similarly in wild-type and GEF-H1-deficient macrophages (Fig. 2c).
We further found that the RIG-I ligand 5′ppp-dsRNA and Mda5 ligand HMW poly(I:C)
induced p65 phosphorylation and IκBα degradation in GEF-H1-deficient and wild-type
macrophages over a period of 4 h (Fig. 2d). Both, GEF-H1-deficient and wild-type
macrophages also responded within 15 minutes with comparable NF-κB activation to TLR4
activation (Fig. 2d). This data indicated that GEF-H1 function was required for IRF3
activation in the RLR pathway but dispensable for p65 activation in the TLR4 and RLR
pathways.
Furthermore, GEF-H1-deficient macrophages showed significantly less Ifnb1 promoter
activation in response to MAVS expression compared to wild-type macrophages while GEF-
H1 expression enhanced Ifnb1 promoter activation in wild-type macrophages and
complemented MAVS-induced IFN-β responses in GEF-H1-deficient macrophages (Fig.
2e).
We further found that GEF-H1 enhanced MAVS signaling leading to the activation of a
p561 interferon-stimulated response element (ISRE)-containing promoter that is activated by
IRF3, but not NF-κB24 (Fig. 2f). GEF-H1 increased ISRE-induced transcriptional activity
10-fold compared to MAVS expression alone in HEK293T cells (Fig. 2f). Indeed, GEF-H1
augmented MAVS-dependent phosphorylation of endogenous IRF3 in HEK293T cells
without significantly altering the baseline expression of IRF3 or TBK1 (Fig. 2g).
To further characterize the role of GEF-H1 in signaling of intracellular nucleotide receptors
and induction of Ifnb1 promoter activation, we utilized HEK293T cells that lack TLR3,
TLR4, TLR7/8 and TLR9. We assembled Mda5 or RIG-I signaling pathways in HEK293T
cells in the absence or presence of GEF-H1 to assess the activation of a luciferase reporter
containing the Ifnb1 promoter in response to RLR ligands. GEF-H1 expression significantly
enhanced Ifnb1 promoter activation induced by the expression of Mda5 and RIG-I alone and
further enhanced Mda5-mediated detection of HMW poly(I:C) and RIG-I-dependent
responses to LMW poly(I:C) and 5′ppp-dsRNA (Fig. 2h). In contrast to RIG-I and Mda5,
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tGEF-H1 expression in HEK293T cells did not induce Ifnb1 promoter activation by itself or
rendered HEK293T cells responsive to RLR stimulation when expressed alone (Fig. 2h).
Together these data demonstrated that GEF-H1 functions in conjunction with RLRs,
enhancing the detection of intracellular poly(I:C) and 5′ppp-dsRNA and leading to the
activation of the Ifnb1 promoter.
The phosphorylation, dimerization and nuclear translocation of IRF3 for the activation of
IFN-β transcription require IKKε and TBK123. Indeed, expression of either TBK1 or IKKε
enhanced Ifnb1 promoter activation in HEK293T cells (Fig. 2i). GEF-H1 expression
significantly enhanced Ifnb1 promoter activation by TBK1 alone or in conjunction with
IKKε (Fig. 2i). In contrast, GEF-H1 did not augment TBK1 or IKKε mediated Nfkb1
promoter activation (Fig. 2i). Furthermore, the promotion of IRF3 and Ifnb1 gene promoter
activation by GEF-H1 was dependent on functional TBK1 and therefore absent in the
presences of a TBK1 kinase-inactive (K38A) mutant (Fig. 2j). Together these data
demonstrate that GEF-H1 can function in the RLR pathway in conjunction with MAVS and
TBK1/IKKε to enhance the phosphorylation of IRF3 and activation of the Ifnb1 promoter.
GEF-H1 mediates microtubule-dependent RLR signaling
To better define the functional domains of GEF-H1, we created GEF-H1 variants by
exchanging the tyrosine at position 393 with alanine to disable the GTP loading capacity of
the Dbl homology domain (ΔDH)25, by replacing serine 885 with alanine (S885A) to
prevent phosphorylation that inhibits GEF activity of GEF-H1 or by substituting cysteine 53
with an arginine (C53R) in the n-terminal zinc finger domain that is required for association
of GEF-H1 with microtubules26,27. We expressed GFP-tagged GEF-H1 or its active mutants
GEF-H1 (S885A) and GEF-H1 (C53R) or its GEF-deficient mutants to determine
subcellular localization and association with the microtubule network. Confocal microscopy
revealed that GEF-H1 or GEF-H1 (S885A) induced the formation of microtubules that
formed aggregations and long curved filaments that contained α-tubulin (Fig. 3a). GEF-H1
ΔDH was found in the cytoplasm and co-localized with microtubules, but failed to induce
microtubule aggregations (Fig. 3a). GEF-H1 (C53R) was unable to bind microtubules and
therefore was found expressed in the cytoplasm and in intracellular aggregations (Fig. 3a).
Both the microtubule associating active GEF-H1 (S885A) and the cytoplasmic GEF-H1
(C53R) mutants significantly enhanced MAVS signaling when expressed in HEK-293T
cells (Fig. 3b). In contrast, we found that the DH domain of GEF-H1 was required for the
amplification of MAVS-induced Ifnb1 promoter activation (Fig. 3c). Furthermore, the ΔDH
variant of GEF-H1 failed to enhance TBK1-mediated Ifnb1 promoter activation; together
indicating that IRF3 activation in the presence of GEF-H1 was dependent on nucleotide
exchange activity by GEF-H1 (Fig. 3d). Indeed, MAVS-induced Ifnb1 promoter activation
was abrogated in the presence of a dominant negative RhoAT19N mutant (Fig. 3e).
Since GEF-H1 is sequestered on microtubules where its GEF function is inhibited by
phosphorylation of S8855, we hypothesized that activation of GEF-H1 by dephosphorylation
and release from microtubules may be required for RLR signaling. Immunostaining with
antibodies directed against α-tubulin or phalloidin staining revealed intact microtubule and
actin networks in unstimulated and poly(I:C)-stimulated wild-type and GEF-H1-deficient
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tmacrophages (Supplementary Fig. 3c,d). However, upon disruption of microtubules,
macrophages failed to initiate Ifnb1 transcription after poly(I:C) and 5′ppp-dsRNA
stimulation (Fig. 3f), although nocodazole treatment of macrophages did not prevent the
uptake of poly(I:C) into macrophages (Supplementary Fig. 3e). Nocodazole treatment also
reduced STING-mediated Ifnb1 mRNA expression in macrophages in response to c-di-GMP
(Fig. 3g). The induction of TRIF-dependent IFN-β expression upon TLR4 activation in
macrophages remained unchanged in the presence of nocodazole and thus occurred
independent of the microtubule formation in macrophages (Fig. 3f).
We further found that a functional microtubule network was required for the interaction of
GEF-H1 with TBK1 because GEF-H1-containing complexes lacked TBK1 in the presence
of nocodazole, while neither TBK1 nor GEF-H1 expression was impaired under these
conditions (Fig. 4a,b).
TBK1-containing signaling complexes preferably contained GEF-H1 that was
dephosphorylated at S885 (Fig. 4c). Potential protein phosphatases that are associated with
microtubule function, activated by foreign RNA and targeted by viral mediators include
protein phosphatase 2A (PP2A)28. Inhibition of PP2A for 40 minutes using 1 nM okadaic
acid, enhanced S885 phosphorylation of GEF-H1, but reduced its association with TBK1-
containing signaling complexes (Fig. 4c,d). We also found reduced GEF-H1 in association
with TBK1 after addition of forskolin (Fig. 4c), to stimulate the activation of adenylyl
cyclase, increasing cellular concentrations of cAMP and subsequent S885 phosphorylation
of GEF-H1 by protein kinase A (PKA)26 (Fig. 4d).
Functionally, GEF-H1 phosphorylation by forskolin or okadaic acid prevented the induction
of IFN-β in macrophages by poly(I:C) but failed to impede Ifnb1 expression in response to
LPS (Fig. 4e). Furthermore, GEF-H1 was dephosphorylated when the RLR signaling
pathway was activated by infecting COS-7 cells with NS1-deficient Influenza A (A/PR/8/34
ΔNS1) (Fig. 4f).
In aggregate, these data are consistent with a multistep activation and release of GEF-H1
from microtubules to make its GEF activity available for amplification of RLR-mediated
activation of TBK1-IKKε-dependent Ifnb1 promoter activation.
GEF-H1 functions in ssRNA virus detection
Thus far our data indicated that GEF-H1 regulates MAVS-dependent utilization of TBK1
for IRF3 phosphorylation and nuclear translocation for type I IFN induction. Furthermore,
macrophages derived from Arhgef2−/− mice were impaired in response to 5′ppp-dsRNA and
poly(I:C) stimulation but responded to TLR activation with type I IFN secretion, indicating
that GEF-H1 functions in the RIG-I and Mda5-dependent induction of type I IFNs for
antiviral defense.
We next assessed susceptibility of GEF-H1-deficient macrophages to distinct RNA viruses
that activate the innate immune system to varying degree through RLRs and TLRs and
compared the innate immune responses to those elicited in MAVS-deficient macrophages.
Encephalomyocarditis virus (EMCV) is a positive-sense ssRNA virus of the Picornaviridae
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tthat is primarily detected by Mda5-dependent host responses16. GEF-H1-deficient
macrophages were severely impaired in their ability to respond to EMCV infection with
IFN-β secretion compared to wild-type macrophages when infected at the multiplicity of
infection (MOI) of 0.1 (Fig. 5a). The reduction in IFN-β secretion was similarly observed in
MAVS-deficient macrophages upon infection with EMCV (Fig. 5a). This effect was likely
due to reduced IRF3 phosphorylation in the absence of GEF-H1 (Fig. 5b), since NF-κB
activation was similar in GEF-H1-deficient, MAVS-deficient and wild-type macrophages 16
h after EMCV infection (Fig. 5c). As a consequence of reduced IFN-β secretion, virus
replication was enhanced in GEF-H1-deficient macrophages as indicated by the significantly
increased expression of transcripts encoding for EMCV non-structural protein 2A and 2B
(Fig. 5d). Together, these experiments indicated that GEF-H1, MAVS and Mda5 are
similarly required for host defense activation to EMCV.
Influenza A (Puerto Rico 8/1934 strain, PR/8/1934), is recognized by RIG-I16 and DHX929.
However, TLR7 contributes to type I interferon secretion by plasmacytoid dendritic cells to
the virus Influenza A30. We assessed IFN-β expression in GEF-H1-deficient macrophages
after infection with a non-structural protein (NS)1-deficient influenza A variant31, that is
unable to inhibit host IFN-β responses during viral replication. GEF-H1-deficient
macrophages lacked nuclear translocation of IRF3 in response to NS1-deficient influenza A
infection (Fig. 5e), although the cytoplasmic amounts of IRF3 were comparable to wild-type
macrophages (Fig. 5f). Consequently, GEF-H1-deficient macrophages secreted significantly
less IFN-β at 8 and 12 h after infection compared to wild-type macrophages (Fig. 5g). The
reduction in IFN-β secretion was similarly observed in MAVS-deficient macrophages upon
infection with NS1-deficient influenza A (Fig. 5g). However, NF-κB activation in response
to NS1-deficient influenza A infection was independent of GEF-H1 and MAVS in
macrophages (Fig. 5h). This suggested that alternative pathways contribute to IFN-β
secretion in response to Influenza A infection that are not impaired in either GEF-H1 or
MAVS-deficient macrophages. Despite reduced IFN-β expression, GEF-H1-deficient
macrophages demonstrated increased expression of Influenza A nucleoprotein (NP)
indicating enhanced viral replication compared to wild-type macrophages (Fig. 5i). Even
when we infected NS1-sufficient influenza A, Ifnb1 mRNA induction was significantly
reduced in GEF-H1-deficient macrophages 12 and 24 h after infection (Fig. 5j). Moreover,
viral replication was enhanced as measured by NS1 RNA expression and the replication of a
recombinant influenza virus carrying a GFP reporter gene in the NS segment32 in GEF-H1-
deficient macrophages (Fig. 5k and Supplementary Fig. 4a).
Vesicular stomatitis virus (VSV) is a negative single stranded rhabdovirus that activates
IFN-α/β through RIG-I, but not protein kinase R (PKR), Mda5 or TLR316,33. However,
glycoprotein G of VSV is a ligand for TLR4 and can trigger IFN-α/β production
independent of RIG-I33. At a functional level TLR4 and MAVS or RIG-I-dependent type I
IFN production appear non redundant since both MAVS-deficient mice and TLR4 mutant
mice are highly susceptibility to VSV33,34. We found that GEF-H1-deficient macrophages
were impaired in the ability to restrict VSV replication (Supplementary Fig. 4b-d). In these
experiments, we infected macrophages from Arhgef2−/− mice and wild-type littermates with
an MOI of 0.1 with VSV and followed virus production in the supernatants over two days by
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tinfecting BHK cells. Beginning 4 h after infection, GEF-H1-deficient BMDMs produced
0.8-1.3 log phase higher amounts of active virus for 24 h compared to wild-type
macrophages (Supplementary Fig. 4b). However, VSV infection of GEF-H1 or MAVS-
deficient macrophages induced IFN-β at similar amounts to infected macrophages with
intact Arhgef2 loci 12 to 48 h after infection. (Supplementary Fig. 4c and d). This is
consistent with the finding that TLR4 signaling leading to IFN-β expression remained intact
in GEF-H1-deficient macrophages and indicated that GEF-H1 selectively controlled RLR-
dependent antiviral defense.
GEF-H1 functioned in mediating RLR recognition of viral RNA rather than by mediating
type I interferon signaling, since IFN-α/β receptor activation leading to the phosphorylation
of STAT1 was intact in GEF-H1-deficient macrophages (Supplementary Fig. 4e).
Finally, we determined innate host defense responses in GEF-H1-deficient macrophages to
Salmonella typhimurium. The recognition of S. typhimurium is for the most part mediated by
TLR2, TLR4 and TLR5 when cultured under conditions that favor Salmonella pathogenicity
island 2 (SPI-2) expression35. GEF-H1-deficient macrophages expressed comparable Ifnb1
and Tnf mRNA levels to wild-type macrophages after infection with S. typhimurium
(Supplementary Fig. 5a, b). Further, absence of GEF-H1 expression did not protect
macrophages from invasion and intracellular replication of S. typhimurium (Supplementary
Fig. 5c). Together these data demonstrate that GEF-H1 facilitates RIG-I and Mda5-
dependent host defenses to viral pathogens without preventing the activation of IFN-α/β or
TLR receptor signaling in macrophages.
Host defense against influenza requires GEF-H1
We next assessed the susceptibility of Arhgef2−/− mice to influenza A infection to determine
whether GEF-H1 was required for antiviral innate immune responses in vivo. We first
determined whether alveolar macrophages of GEF-H1-deficient mice were impaired in
recognizing poly(I:C). Bronchoalveolar fluid from GEF-H1-deficient mice lacked detectable
IFN-β when challenged intranasally with poly (I:C), whereas wild-type mice secreted
significant amounts of IFN-β in the airways in response to the same challenge (Fig. 6a). We
also isolated alveolar macrophages and examined the concentration of IFN-β secretion after
the initial intranasal challenge with poly(I:C) in vivo and assessed their responsiveness to
additional challenges with poly(I:C). While alveolar macrophages from wild-type littermates
significantly increased IFN-β secretion upon re-stimulation in vitro, no detectable IFN-β was
released from GEF-H1-deficient alveolar macrophages after isolation or following re-
stimulation in vitro suggesting a severe defect in the recognition of poly(I:C) by alveolar
macrophages which we hypothesized would impair viral defense in these mice (Fig. 6b).
Indeed, GEF-H1-deficient mice were more susceptible to Influenza A infection compared to
wild-type littermates. Four days after Influenza A infection, alveolar macrophages from
GEF-H1-deficient mice expressed significantly lower levels of Ifnb1 and Il6 mRNA (Fig.
6c). Additionally, lungs of GEF-H1-deficient mice demonstrated significantly more signs of
severe inflammation, with increased epithelial damage, mononuclear cell infiltrates, and
alveolitis (Fig. 6d). This suggests that GEF-H1 is required for IFN-β induction for antiviral
responses against influenza A infection.
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GEF-H1-deficient macrophages have a profound defect in the induction of IFN-β following
detection of synthetic dsRNAs including HMW and LMW poly(I:C) and 5′ppp-dsRNA. The
inability to induce IFN-β in the absence of GEF-H1 was not due to impaired uptake of
ligands or differential expression of signaling intermediates, but the requirement of the
nucleotide exchange activity of GEF-H1 and polarized microtubules for RLR signaling. In
macrophages GEF-H1 is dephosphorylated and released from microtubules during RLR
activation and promotes IRF3 activation. Disruption of microtubule polarization prevents
activation of GEF-H1 and consequently RLR signaling. Remarkably, TRIF and MyD88
dependent activation of IFN-β and proinflammatory cytokine expression was neither
dependent on GEF-H1 nor nocodazole sensitive microtubule formation, suggesting that
GEF-H1 has a distinct spatial function that is required for the activation of TBK1-IKKε in
the RLR pathway (Supplementary Fig. 6).
Viral pathogens often target dynein machinery components with effectors to utilize the
microtubule system for transport in host cells3. GEF-H1 may serve as gatekeeper on
microtubules to locally modulate the activity of GTPases that in turn are responsible for the
initial polarization of the microtubule cytoskeleton to facilitate antiviral responses36.
Recently the microtubule network has been demonstrated to mediate the aggregation of
mitochondria to facilitate the activity of the NLRP3 inflammasome37. Rho GTPase
activation by GEF-H1 may stabilize actin association with mitochondria that occurs during
RIG-I signaling during influenza A infection of macrophages38. In this context, GEF-H1
could regulate local Rho GTPase activation to promote stabilizing microtubules39 or
membrane compartments as signaling platforms that allow GEF-H1 to interact with TBK1-
IKKε containing signaling complexes. Furthermore, GEF-H1 may regulate the distribution
of mitochondria within cells that requires crosstalk between microtubule and actin
cytoskeleton through Rho GTPase activation40.
GEF-H1 and MAVS-deficient macrophages were impaired in RLR signaling leading to
IRF3 activation. In contrast, NF-κB activation by surface and endosomal TLRs involved in
the detection of viral RNA and viral glycoprotein remained intact in GEF-H1-as well as
MAVS-deficient mice. Although TRIF-dependent TLR signaling can activate TBK141 and
IRF3 activation42, we showed that in macrophages LPS stimulation induced primarily NF-
κB activation. This is consistent with the finding that TLR-dependent NF-κB activation can
occur independent of TBK141 but still can control IFN-β expression43 since the IFN-β
promoter contains IRF3 and NF-κB sites that are utilized for induction by different signaling
pathways44. Conversely, NF-κB is dispensable for IFN-β activation by RLRs that is
mediated by IRF3 activation45,46.
GEF-H1 was not required for IFN-β secretion initiated by ligand binding to TLR1/2, TLR2,
TLR2/6, TLR4, TLR5, TLR7 and TLR9 activation in macrophages. In addition, the
induction of proinflammatory cytokines by TLR4 activation, which requires both MyD88-
and TRIF-dependent signals47, was intact in GEF-H1-deficient macrophages. We further
demonstrate that innate immune responses to viruses whose RNA or glycoptroteins also
activates TLRs or invasive bacteria that activate TLRs were able to induce IFN-β expression
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teven in the absence of GEF-H1 or MAVS. However the current experiments do not exclude
a further function of GEF-H1 in TLR signaling in different cell types or in response to
distinct pathogens that have different effector functions to evade host detection.
Our experiments demonstrate that GEF-H1-deficient macrophages fail to activate IRF3 but
not NF-κB in response to ssRNA viruses. Because both IRF3 and NF-κB activate IFN-β, the
role of GEF-H1 may depend on the degree to which antiviral host response to a particular
pathogen includes the activation of RLR and TLR pathways. GEF-H1- and MAVS-deficient
macrophages responded similarly to infection with EMCV with a profound lack of IFN-β
secretion. Thus GEF-H1 is required for the recognition of EMCV infection that primarily
occurs through Mda515,16. Mda5 is required and dominant over TLR3 for type I IFN
induction by uncomplexed poly(I:C) in bone marrow-derived macrophages and DCs in
vitro15 and we therefore cannot exclude a role of GEF-H1 in TLR3 signaling in different
cell types.
GEF-H1- as well as MAVS-deficient macrophages demonstrate a significant reduction in
IFN-β secretion in response to influenza A infection. In conventional dendritic cells and
macrophages, RIG-I is required for the detection of influenza virus and induction of type I
IFN via recognition of 5′-triphosphates on genomic ssRNA, which are generated after viral
fusion and replication19. Our data demonstrate RIG-I activation in response to 5′ppp-dsRNA
was impaired in GEF-H1-deficient macrophages resulting in attenuation of IRF3
phosphorylation, nuclear translocation and Ifnb1 gene transcription. Furthermore, GEF-H1-
deficient alveolar macrophages failed to respond directly to stimulation or re-stimulation
with poly(I:C) with IFN-β secretion. GEF-H1 was essential for host response to Influenza A,
which was pronounced during infection with an NS1-deficient influenza A variant that lacks
the ability of the wild-type virus to inhibit type I IFN secretion. It will be important to
determine whether NS1 targets GEF-H1 function in host cells for immune evasion since
variants of NS1 can regulate viral RNA load and RIG-I-mediated innate immune activation
through mechanisms that may include targeting Rho GTPase function but have not been
fully established48.
Our data indicate that GEF-H1 and polarization of microtubules are also required for the
recognition of c-di-GMP that induces STING-mediated activation of TBK1 and IRF322. c-
di-GMP serves as an important non-coding RNA binding second messenger in bacteria
regulating the expression of many virulence genes49. Through binding to DDX41 and
STING, c-di-GMP is recognized as a pathogen-associated molecular pattern that triggers the
host type I interferon innate immune response22. Thus the role of GEF-H1 in the activation
of IRF3 may also mediate DDX protein functions for the induction of type I interferon
responses to bacterial infections. It will be important to define the role of GEF-H1 in other
STING-dependent recognition pathways that include a large number of proposed sensors for
cytosolic DNA sensing whose role in antimicrobial immunity and viral defense activation is
currently being investigated50
In conclusion, our findings identify GEF-H1 as an antiviral signaling component that directs
utilization of TBK1-IKKε in the MAVS-dependent nucleic acid detection pathways for the
sensing of ssRNA virus infection and induction of IFN-β expression and secretion. GEF-H1
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and thus understanding of the underlying molecular mechanisms of GEF-H1 activation and
release from microtubules could lead to new therapeutic strategies against viral infection.
ONLINE METHODS
Generation of Arhgef2−/− mice
Arhgef2−/− mice were generated using the gene-trap ES cell clone IST13976A8 for Arhgef2
from the Texas Institute of Genomic Medicine (TIGM). ES cell clone were microinjected
into C57BL/6 blastocysts. Chimeric offspring were used for the generation of homozygous
mice for the targeted null allele (Arhgef2−/−). Genotyping was performed by PCR of tail
genomic DNA using two sets of primers: F139_1, 5′-agtcccctgtccagtggtttacc-3′ and R_V76,
5′-ccaataaaccctcttgcagttgc-3′; F_V76, 5′-cttgcaaaatggcgttacttaagc-3′ and R139_4, 5′-
agactcagggtcactggttgtga-3′ to produce amplicons that span the gene-trap vector junction to
distinguish the Arhgef2− allele from the Arhgef2+ allele. PCR of tail genomic DNA was
performed to distinguish the Arhgef2+ allele from the Arhgef2− allele using the F139_1 and
R139_4 primers to produce an amplicon that spans the gene-trap vector insertion site. GEF-
H1 mRNA was confirmed by RT-PCR using a forward primer spanning from exon 4~5
junction, 5′-aggcaaccaagacccgggaaaa-3′ and a reverse primer located in exon 12, 5′-
taaggccttggtgtggcggc-3′. GEF-H1 protein expression was confirmed by immunoblotting.
Mice were housed in pathogen-free barrier facilities. Arhgef2−/− and littermate control mice
were used throughout the experiments. All animal experiments were performed according to
animal protocols approved by the Subcommittee on Research Animal Care at Massachusetts
General Hospital. Unless otherwise indicated, experiments used sex-matched littermates at
8-12 weeks of age.
Cells and reagents
HEK293T and COS-7 cells were purchased from American Type Culture Collection and
maintained in DMEM supplemented with 10% fetal bovine serum and 0.5% penicillin/
streptomycin mixture and tested to be free of mycoplasma. Bone marrow-derived
macrophages were generated in DMEM containing 10% FBS, 0.5% penicillin/streptomycin
mixture, and 20 ng/ml M-CSF for 5-7 days. Control dsRNA, 5′ppp-dsRNA, LMW
poly(I:C), HMW poly(I:C), LPS,c-di-GMP, Pam3CSK4, HKLM, Flagellin, FSL-1, ssRNA,
and CpG ODN1826 were purchased from Invivogen. Nocodazole and gentamicin solution
was obtained from Sigma. Forskolin and okadaic acid were purchased from Abcam.
Plasmids and antibodies
Plasmids encoding VSV-tagged GEF-H1, RhoA, RhoAT19N, and RhoAG14V have been
described previously7. Plasmid encoding FLAG-tagged GEF-H1 (pCMV6-Entry-hGEF-H1)
and GFP-tagged GEF-H1 (pCMV6-AC-GFP-hGEF-H1) were purchased from OriGene.
FLAG-GEF-H1 (Y393A, ΔDH), GFP-GEF-H1 (Y393A, ΔDH), GFP-GEF-H1 (S885A), and
GFP-GEF-H1 (C53R) mutations were generated using the Quikchange Site-Directed
Mutagenesis Kit (Stratagene). pEF-BOS-huTBK1, pEF-BOS-huTBK1K38A, pcDNA3-
IKKε-flag, pEF-BOS-huMAVS, pEF-BOS-huRIG-I and pEF-BOS-huMDA5 plasmids were
obtained from Addgene. P561-luc-IRF3 firefly reporter was kindly provided by Xiaoxia Li
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t(Cleveland Clinic, Cleveland, OH). The pGL4.20(luc2/puro)-IFNβ firefly luciferase
promoter reporter was a gift from Tilmann Bürckstümmer (Austrian Academy of Sciences,
Vienna, Austria). pNF-κβ firefly luciferase and pRL-TK Renilla plasmids were obtained
from ClonTech. Horseradish peroxidase-anti-FLAG (M2; F1804) and anti-VSV (P5D4;
V5507) antibodies were obtained from Sigma. Anti-GEF-H1 phosphorylated at S885
(ab74156), anti-IRF3 (D83B9; 4302), anti-IRF3 phosphorylated at Ser396 (4D4G; 4947),
anti-TBK1 (D1B4; 3504), anti-MAVS (3993), anti-STAT1 (9172), anti-STAT1
phosphorylated at Tyr701 (58D6; 9167), anti-IKKε (D61F9; 3416), anti-IκBα (L35A5;
4814), anti-p65 phosphorylated at S536 (93H1; 3033), anti-p65 (D14E12; 8242), anti-β-
actin (8H10D10; 3700), and anti-PCNA (D3H8P; 13110) antibodies were purchased from
Cell Signaling Technology. Anti-α-tubulin antibody (ab4074) was obtained from Abcam.
Anti-GEF-H1 antibody (x1089p) was purchased from Exalpha Biologicals. Alexa Fluor 488
Phallodin was obtained from Invitrogen. Anti-influenza A/PR/8/34 nucleoprotein antibody
was a gift from Adolfo García-Sastre (Mount Sinai School of Medicine, New York, NY).
FITC-conjugated donkey anti-sheep IgG (H+L) (713-095-147) and Cy3-comjugated donkey
anti-rabbit IgG (H+L) (711-165-152) antibodies were purchased from Jackson
ImmunoResearch Laboratories.
Immunoprecipitation and immunoblotting
HEK293T cells were transfected with indicated plasmids using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s protocol. For the experiment of GEF-H1 and
TBK1 interaction, HEK293T cells were first transfected with GEF-H1-VSV and TBK1-Flag
plasmid by Lipofectamine 2000 for 24 h, then were treated with nocodazole (1 or 10 μM),
forskolin (10 μM), or okadaic acid (1 nM) for 40 minutes followed by immunoprecipitation
and immunoblotting. The preparation of cell total lysates for immunoprecipitation and
immunoblotting has been described previously7. Nuclear and cytoplasmic extracts from
bone marrow-derived macrophages were prepared according to published methods41 with
modifications: buffer A (10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 0.1 mM EDTA, 0.1
mM EGTA, 1 mM DTT, 0.3 mM Na3VO4) and buffer C (20 mM HEPES, 1.5 mM MgCl2, 1
mM EDTA, 1 mM EGTA, 1 mM DTT, 0.3 mM Na3VO4, 0.4 M NaCl, 1 mM PMSF).
Densitometry analysis of Immunoblots was done by ImageJ (NIH).
Viruses and viral infection
Influenza A virus (PR/8/1934), A/PR/8/1934 ΔNS1, A/PR/8/1934 NS1-GFP and anti-NP
antibody were kindly provided by Adolfo García-Sastre (Mount Sinai School of Medicine,
New York, NY). EMCV was purchased from ATCC. VSV was a gift from Charles Rice and
Margaret MacDonald at The Rockefeller University. Bone marrow-derived macrophages
from WT and Arhgef2−/− mice were infected with virus in DPBS with 1% FBS at indicated
MOI for 1 h. Infection was continued for various times in the presence of serum-containing
DMEM. For the in vivo influenza A/PR/8/1934 infection, Arhgef2−/− mice and their
littermate controls were anesthetized and challenged with 20 μl (10 μl per nostril) of
influenza A/PR/8/1934 suspension (103 pfu) intranasally.
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tPlaque assay
Supernatants from infected cells were used to measure viral titers by plaque assays.
Monolayers of BHK-21 cells were used for VSV plaque assays. After 1 h of viral infection,
BHK-21 cells were overlaid with 1.5% LE agarose for 1 day. The cells were then fixed with
7% formaldehyde followed by crystal violet staining. Plaques were counted to determine the
titers.
Bacterial infection
Salmonella enterica serovar typhimurium strain SL1344 was used. Bacterial cultures were
prepared by inoculating 10 ml of LB with 0.01 ml of a stationary phase culture, followed by
a 16 h incubation at 37°C. Bone marrow derived macrophages were spininfected at moi=10
for 15 minutes at 750 rpm followed by incubation at 37°C for 45 minutes. Cells were
washed twice before the addition of 100 μg/ml gentamicin in DMEM with 10 % FBS. 1 h
after infection, macrophages were given fresh DMEM medium containing 10% FBS and 10
μg/ml gentamicin for the reminder of the experiment. For the determination of intracellular
replication of S. typhimurium, cells were lysed in 1% Triton X-100 in PBS. Lysates were
serially diluted in DMEM and plated on LB agar plates containing 100 μg/ml streptomycin
for colony enumeration.
Gene expression analysis
Mouse bone marrow-derived macrophages and alveolar macrophages were isolated and
treated as described above. Qiagen RNeasy kit was used for the extraction of RNA from all
cell types examined and, after synthesis of cDNA with iScript cDNA synthesis kit (Bio-
Rad), iQ SYBR Green Supermix kit (Bio-Rad) was used for real-time PCR (Bio-Rad
CFX96 Real-Time PCR Detection System) according to the manufacturer’s specifications.
The value obtained for each gene was normalized to that of the GAPDH gene. Primers were
as follows: IFN-β forward, 5′-ccctatggagatgacggaga-3′, and reverse, 5′-
ctgtctgctggtggagttca-3′; IL-6 forward, 5′-ctgatgctggtgacaaccac-3′, and reverse, 5′-
tccacgatttcccagagaac-3′; TNFα forward, 5′-tagccaggagggagaacaga-3′, and reverse, 5′-
ttttctggagggagatgtgg-3′; GAPDH forward, 5′-aactttggcattgtggaagg-3′, and reverse, 5′-
ggatgcagggatgatgttct-3′; Influenza NS1 forward, 5′-tcgagacagccacacgtgctggaaa-3′; Influenza
NS1 reverse, 5′-aagagggcctgccactttctgcttg-3′; EMCV 2A-2B forward, 5′-
aatgcccactacgctggt-3′; EMCV 2A-2B reverse, 5′-gtcgttcggcagtagggt-3′.
Measurement of cytokine production
Concentration of IFN-β in cell culture supernatants was measured using commercial ELISA
kits (PBL interferon source) or Luminex assays (Affymetrix) according the manufacturers’
instructions.
Luciferase assay
HEK293T cells were transfected with 50 ng of IFNβ, p561, or NF-κB firefly luciferase
reporter and 0.5 ng of pRL-Renilla reporter together with expression plasmids by
Lipofectamine 2000. For control experiments, empty pcDNA3.1 were utilized. Transfection
of WT and Arhgef2−/− macrophages was carried out using Amaxa Mouse Macrophage
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tNucleofector kits. Luciferase assays were performed 24 h post transfection using the Dual-
Luciferase Reporter Assay System (Promega) according to the manufacturer’s instructions.
Flow cytometry
Isolated cells from spleen and mesenteric lymph nodes were incubated in 10% donkey
serum and Fc block for 20 minutes at 4°C and then stained with the following fluorescent-
conjugated antibodies: APC-conjugated anti-CD11c (HL3; 550261), PE-conjugated anti-
F4/80 (6F12; 552958), PE-conjugated anti-CD103 (M290; 557495), APC-Cy7-conjugated
CD4 (GK1.5; 552051), PerCP-conjugated CD8 (53-6.7; 553036), FITC-conjugated anti-
NK1.1 (PK136; 553164), and APC-conjugated a anti-CD19 (1D3; 550992). All antibodies
were obtained from BD Pharmingen. Cells were analyzed on a FACSCalibur flow cytometer
(BD Bioscience) and analyzed by FlowJo (Tree Star).
Confocal microscopy
WT or Arhgef2−/− bone marrow-derived macrophages were plated on 4-well chamber
coverglass (Lab-Tek) and stimulated with poly(I:C)-Rhodamine or infected with influenza
A/PR/8 NS1-GFP at indicated time periods. Live cells were imaged with a Nikon A1R-A1
confocal microscope. Image acquisition was carried out with NIS-Elements imaging
software (Nikon) followed by analyses by Volocity (PerkinElmer). Immunofluorescence
staining and imaging were performed as previously described7.
Sampling BAL fluid and alveolar macrophages
Bronchoalveolar lavages were recovered by cannulation with 1000 μl of PBS after terminal
exsanguination. To obtain alveolar macrophages, cells were washed and then enriched by
centrifugation.
Histopathology analysis
To assess histological changes of lung following infection with influenza A/PR/8/1934
infection, anesthetized mice were exsanguinated via the abdominal aorta, and their lung
tissues were fixed in 4% formaldehyde overnight at 4°C. The tissues were dehydrated by
gradually soaking in alcohol and xylene and then embedded in paraffin. Specimens were cut
into 5 μm sections and stained with Hamp;E. Lung sections were evaluated ‘blinded’ to
sample identity and scored based on assessments of lung tissue destruction, epithelial cell
layer damage, polymorphonuclear cell infiltration into the inflammation site, and alveolitis
on a scale of 0-5 each parameters (0, none; 5 severe).
Statistical Analysis
GraphPad Prism was used for all statistical analysis. Total sample size was determined
based on the previous studies with similar genetically modified mouse with comparable
functional defects. All experiments were repeated at least three times. Statistical analysis
was carried out by two-way analysis of variance (ANOVA) followed by Student’s t-test. A
P value < 0.05 was considered statistically significant.
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Refer to Web version on PubMed Central for supplementary material.
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GEF-H1 is essential for RLR-mediated IFN-β production. (a) Schematic diagram of the
gene-trap vector and its site of insertion into Arhgef2 gene. GEF-H1 mRNA expression in
wild-type (WT), Arhgef2 heterozygous (+/-), and Arhgef2 homozygous (−/−) mice was
determined by RT-PCR. (b) Immunoblot analysis of GEF-H1 expression in WT and
Arhgef2−/− macrophages. (c, d) Quantitative RT-PCR analysis of Ifnb1 mRNA expression in
WT and Arhgef2−/− macrophages incubated for 16 h with transfected (c) 5′ppp-dsRNA (0.5
μg/ml), HMW poly(I:C) (0.5 μg/ml) or c-di-GMP (10 μg/ml) and (d) Pam3CSK4 (1 μg/ml),
HKLM (108 cells/ml), LPS (0.2 μg/ml), Flagellin (1 μg/ml), FSL-1 (1 μg/ml), ssRNA (1
μg/ml) complexed with Lipofectamine (lipofect), and CpG ODN1826 (5 μM) complexed
with Lipofectamine. (e-g) IFN-β secretion by WT and Arhgef2−/− macrophages in the
presence of 5′ppp-dsRNA, LMW poly(I:C) or HMW poly(I:C) (0.5 μg/ml) complexed with
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tor without Lipofectamine for 24 h. (h) Immunoblot analysis of GEF-H1 expression in WT
macrophages treated with transfected 5′ppp-dsRNA (0.5 μg/ml) for 1 or 3 h. (i) Quantitative
RT-PCR analysis of Ifnb1 mRNA expression in WT, Arhgef2+/- or Arhgef2−/− macrophages
in the presence of HMW poly(I:C) (0.5 μg/ml) for 24 h. (j) Quantitative RT-PCR analysis of
Il6 and Tnf mRNA expression in WT and Arhgef2−/− macrophages incubated for 24 h with
transfected 5′ppp-dsRNA (0.5 μg/ml). Results are presented relative to the expression of
GAPDH. UT, untreated. ND, not detectable. **, P < 0.01 (Student’s t-test). Data are from
one experiment representative of three independent experiments. Error bars indicate mean ±
SD.
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tFigure 2.
GEF-H1 enhances TBK1-dependent IRF3 activation. (a) IRF3 phosphorylation and
expression in cytoplasmic protein fractions of WT and Arhgef2−/− macrophages in response
to transfected 0.5 μg/ml 5′ppp-dsRNA. (b) IRF3 expression in protein extractions from
nuclei of WT and Arhgef2−/− macrophages in response to transfected 0.5 μg/ml 5′ppp-
dsRNA. (c) Immunoblots of IRF3 phosphorylation in WT and Arhgef2−/− macrophages in
the presence of LPS (0.2 μg/ml). β-actin and PCNA served as loading controls. Bar graphs
represent densitometry analysis of phosphorylated IRF3 relative to IRF3 expression at 4 h.
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t(d) Immunoblot analysis of IκBα expression and p65 phosphorylation at S536 in WT and
Arhgef2−/− macrophages incubated with transfected 0.5 μg/ml 5′ppp-dsRNA, HMW
poly(I:C), or 0.2 μg/ml LPS. (e) Ifnb1 promoter activation 24 h after transfection of WT or
Arhgef2−/− macrophages with combinations of MAVS and GEF-H1 plasmids. (f)
Assessment of MAVS and/or GEF-H1-mediated p561 luciferase reporter activation in
HEK293T cells 24 h after transfection. (g) Immunoblot analysis of IRF3 phosphorylation in
MAVS and/or GEF-H1-transfected HEK293T cells. (h) Ifnb1 promoter activation in
HEK293T cells expressing GEF-H1 and Mda5 or RIG-I in response to HMW poly(I:C),
LMW poly(I:C) or 5′ppp-dsRNA stimulation for 24 h. (i) GEF-H1 and TBK1 or IKKε-
mediated Ifnb1 and Nfkb1 promoter activation in HEK293T cells 24 h after transfection. (j)
Ifnb1 and p561 luciferase reporter activation 24 h after transfection of HEK293T cells with
combinations of GEF-H1, TBK1 or TBK1 kinase-inactive (K38A) mutant plasmids. Data
presented are from one experiment representative of three independent experiments and
represented as fold induction relative to the reporter-only control and reflect mean ± SD. *,
P < 0.05; **, P < 0.01 (Student’s t-test).
Chiang et al. Page 21
Nat Immunol. Author manuscript; available in PMC 2014 July 01.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tFigure 3.
GEF-H1 controls microtubule-dependent induction of IFN-β expression. (a) Confocoal
microscopy of COS-7 cells expressing GFP-tagged GEF-H1, GEF-H1 (S885A), GEF-H1
(ΔDH), and GEF-H1 (C53R). Scale bar, 10μm. (b) Ifnb1 promoter activation by MAVS in
HEK293T cells transfected with GFP-tagged GEF-H1, GEF-H1 (ΔDH), GEF-H1 (C53R)
and GEF-H1 (S885A). (c, d) Ifnb1 promoter activation by MAVS (c) or TBK1 (d) in
HEK293T cells in the presence of GEF-H1 or GEF-H1 (ΔDH). (e) Ifnb1 promoter activation
by MAVS in HEK293T cells 24 h after transfection of RhoA, RhoA dominant negative
variant (RhoAT19N), or constitutive variant (RhoAG14V) plasmids. Data are represented as
fold induction relative to the reporter-only control. (f) Quantitative RT-PCR analysis of
Ifnb1 mRNA expression and IFN-β secretion in nocodazole-treated WT macrophages in the
presence of 0.5 μg/ml transfected 5′ppp-dsRNA, HMW poly(I:C), or 0.2 μg/ml LPS for 24
h. (g) Quantitative RT-PCR analysis of Ifnb1 mRNA expression in nocodazole-treated WT
macrophages in the presence of transfected c-di-GMP (10 μg/ml) for 24 h. Results are
presented relative to the expression of GAPDH. ND, not detectable. Data are from one
experiment representative of three independent experiments and reflect mean ± SD. *, P <
0.01 (Student’s t-test).
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tFigure 4 Polarized microtubules are required for the activation of GEF-H1 and interaction
with TBK1. (a) Immunoprecipitation (IP) with anti-GEF-H1 and immunoblot (IB) for
TBK1-Flag or GEF-H1-VSV expressed in HEK293T cells in the absence or presence of
nocodazole for 40 minutes. (b) IB analysis of cell lysates utilized for the IP in panel a. (c) IP
with anti TBK1 and IB detection of GEF-H1-VSV and GEF-H1 phosphorylated at Serine
885 with specific antibodies in HEK293T cells in the presence of nocodazole (10 μM),
forskolin (10 μM), or okadaic acid (1 nM) for 40 minutes. (d) IB analysis of cell lysates
utilized for IP in panel c. (e) Quantitative RT-PCR analysis of Ifnb1 mRNA expression in 10
μM forskolin or 1 nM okadaic acid-treated WT macrophages in the presence of 0.5 μg/ml
5′ppp-dsRNA complexed with Lipofectamine, or 0.2 μg/ml LPS for 24 h. Results are
represented relative to the expression of GAPDH and reflect mean ± SD. **, P < 0.01
(Student’s t-test). (f) IP with anti-Flag and IB detection of GEF-H1 S885 phosphorylation in
COS-7 cells after infection with NS1-deficient influenza A/PR/8/34. Bar graph represents
densitometry analysis of phosphorylated GEF-H1 relative to GEF-H1 expression. Data are
from one experiment representative of three independent experiments.
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GEF-H1 mediates host defenses against ssRNA viruses. (a) IFN-β secretion by EMCV-
infected (MOI=0.1) WT, Arhgef2−/−, and Mavs−/− macrophages. (b) Immunoblot analysis
of IRF3 phosphorylation in WT and Arhgef2−/− macrophages after EMCV infection
(MOI=0.1). (c) Immunoblot analysis of IκBα expression and phosphorylation of p65 at
S536 in WT, Arhgef2−/− and Mavs−/− macrophages infected with EMCV (MOI=0.1). (d)
Quantitative RT-PCR analysis of EMCV non-structural protein 2A and 2B mRNA in
EMCV-infected (MOI=1) WT or Arhgef2−/− macrophages. (e) IRF3 expression in the
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tnuclear and (f) cytoplasmic protein fractions of WT and Arhgef2−/− macrophages infected
with influenza A lacking the nonstructural protein NS1 gene (A/PR/8 ΔNS1) (MOI=1). (g)
IFN-β expression in the supernatants of macrophages from WT, Arhgef2−/− and Mavs−/−
mice after influenza A/PR/8 ΔNS1 infection (MOI=0.1). (h) Immunoblot analysis of IκBα
expression and phosphorylation of p65 at S536 in WT, Arhgef2−/− and Mavs−/−
macrophages infected with A/PR/8 ΔNS1 (MOI=0.1). (i) Immunoblot analysis of TBK1,
IKKε expression and the presence of A/PR/8 nucleoprotein (NP) in A/PR/8 ΔNS1-infected
WT and Arhgef2−/− macrophages (MOI=0.1). (j, k) Quantitative RT-PCR analysis of Ifnb1
(j) or NS1 (k) mRNA in WT or Arhgef2−/− macrophages after influenza A/PR/8 infection
(MOI=1). (d, j, k) Results are represented relative to the expression of GAPDH. ND, not
detectable. Data are from one experiment representative of three independent experiments
and reflect mean ± SD. *, P < 0.05; **, P < 0.01 (Student’s t-test).
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GEF-H1 is required for the control of influenza A infection. (a) IFN-β secretion in
bronchoalveolar lavage (BAL) fluid in WT and Arhgef2−/− mice (n=3 per group) 6 h post
intranasal administration of LMW poly(I:C). (b) IFN-β secretion after 0.5 μg/ml LMW
poly(I:C) restimulation for 24 h of alveolar macrophages isolated from LMW poly(I:C)-
challenged WT or Arhgef2−/− mice. (c) Quantitative RT-PCR analysis of Ifnb1 and Il6
mRNA in alveolar macrophages from WT and Arhgef2−/− mice (n=3 in each group) 4 days
after influenza A/PR/8 infection. (d) Haematoxylin and eosin staining of WT and Arhgef2−/−
lungs, 4 days post influenza A/PR/8 infection (n=3 per group). Scale bar indicates 0.2 μm.
The bar graph represents pathological scores. Data are from one experiment representative
of three independent experiments. ND, not detectable. *, P < 0.05; **, P < 0.01 (Student’s t-
test). Error bars indicate mean ± SD.
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